Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Mineralys Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Mineralys Therapeutics Inc. May 21, 202699.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Mineralys Therapeutics Inc. | Option exercise | +3,000 | $12.02 | $36,060 |
| Sep 15, 2026 | Mineralys Therapeutics Inc. | Open-market sale | −3,000 | $28.58 | $85,740 |
| Jun 17, 2026 | Mineralys Therapeutics Inc. | Option exercise | +3,000 | $12.02 | $36,060 |
| Jun 17, 2026 | Mineralys Therapeutics Inc. | Open-market sale | −3,000 | $25.00 | $75,000 |
| Mar 31, 2026 | Mineralys Therapeutics Inc. | Option exercise | +3,000 | $12.02 | $36,060 |
| Mar 31, 2026 | Mineralys Therapeutics Inc. | Open-market sale | −3,000 | $25.00 | $75,000 |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Grant or award | +6,200 | — | — |
| Nov 13, 2025 | Mineralys Therapeutics Inc. | Option exercise | +15,000 | $10.20 | $153,000 |
| Nov 13, 2025 | Mineralys Therapeutics Inc. | Open-market sale | −10,115 | $45.81 | $463,368 |
| Nov 13, 2025 | Mineralys Therapeutics Inc. | Open-market sale | −4,885 | $46.36 | $226,469 |
Questions about Daphne Karydas
What boards is Daphne Karydas on?
Daphne Karydas sits on the boards of COMPASS Pathways Plc and Mineralys Therapeutics Inc.
How long has Daphne Karydas served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.